Goswami S, Korgaonkar S, Bhattacharya K, Rosenthal M. Food insecurity in a sample of informal caregivers in 4 southern US states. Prev Chronic Dis. 2022 Aug 18;19:E51. doi: 10.5888/pcd19.220069
Calancie L, Anderson S, Branscomb J, Apostolico AA, Hassmiller Lich K. Using behavior over time graphs to spur systems thinking among public health practitioners. Prev Chronic Dis. 2018 Feb 1;15:E16. doi: 10.5888/pcd15.170254
Mansfield C, Tangka FKL, Ekwueme DU, Smith JL, Guy GP, Li C, Hauber AB. Stated preference for cancer screening: a systematic review of the literature, 1990–2013. Prev Chronic Dis. 2016 Feb 25;13:E27. doi: 10.5888/pcd13.150433
See CW, Srinivasan M, Saravanan S, Oldenburg CE, Esterberg EJ, Ray KJ, Glaser TS, Tu EY, Zegans ME, McLeod SD, Acharya NR, Lietman TM. Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial. Ophthalmic Epidemiol. 2012 Dec;19(6):407-13.
Grogan S, Hartley L, Fry G, Conner M, Gough B. Appearance concerns and smoking in young men and women: going beyond weight control. Drug-Educ Prev Polic. 2010 May 6;17(3):261-9. doi: 10.3109/09687630802422019
Offen W, Chuang-Stein C, Dmitrienko A, Copley-Merriman K. Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the PhRMA. Drug Inf J. 2007;4:31-46.
Backhouse ME, Gnanasakthy A, Schulman KA, Akehurst R, Glick H. The development of standard economic datasets for use in the economic evaluation of medicines. Drug Inf J. 2000;34(4):1273-91.
Ciociola AA, Webb DD, McSorley DJ. The continued use of placebo-controlled clinical trials in the study of peptic ulcer disease: a sponsor perspective. Drug Inf J. 1996 Apr;30(2):433-9.
Doward LC. Developing a measure of quality of life for patients with recurrent genital herpes. Drug Inf J. 1994 Jan 1;28(1):19-25.
Koch GG, Amara LA, Forster JK, McSorley DJ, Peace KE. Statistical issues in the design and analysis of ulcer healing and recurrence studies. Drug Inf J. 1993 Jul;27(3):805-24.